Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials

Carole Fakhry, Qiang Zhang, Maura L. Gillison, Phuc Felix Nguyen-Tân, David I. Rosenthal, Randal S. Weber, Louise Lambert, Andy M. Trotti, William L. Barrett, Wade L. Thorstad, Sue S. Yom, Stuart J. Wong, John A. Ridge, Shyam S.D. Rao, Sharon Spencer, Andre Fortin, David Raben, Jonathan Harris, Quynh Thu Le

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials'. Together they form a unique fingerprint.

Medicine & Life Sciences